A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)

a study on Nonalcoholic Fatty Liver Disease Nonalcoholic Steatohepatitis Steatohepatitis Liver Disease

Summary

Eligibility
for people ages 2 years and up (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.

Official Title

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)

Keywords

Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Liver Diseases, Fatty Liver, Non-alcoholic Fatty Liver Disease

Eligibility

You can join if…

Open to people ages 2 years and up

  1. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.

You CAN'T join if...

  1. Inability to provide informed assent/consent.

Locations

  • University of California, Davis accepting new patients
    Sacramento California 95817 United States
  • California Liver Research Institute accepting new patients
    Pasadena California 91105 United States
  • Stanford University accepting new patients
    Palo Alto California 94304 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Target PharmaSolutions, Inc.
ID
NCT02815891
Study Type
Observational [Patient Registry]
Participants
Expecting 15000 study participants
Last Updated